Rapid assay for detecting mirna: compositions and methods of use
AssigneeMI:RNA Ltd.
InventorsEve HANKS, Robert COULTOUS
Life of this patent
Estimating the term…
Abstract
An diagnostic assay for rapidly detecting level of expression of mRNA within low volume or low expression samples by proxy of generated cDNA. The method provides for the detection of cDNA of a diseased subject with at least one pre-determined reference level cDNA characteristic of a non-diseased subject wherein a deviation of the level of expression of said cDNA in comparison with the at least one reference level cDNA allows for the diagnosis and/or prognosis of the disease.
Claims19
A method for detecting the presence of mycobacterial disease in a subject, comprising the steps of:
- (a) isolating miRNA molecules within a sample from a subject;
- (b) translating the miRNA molecules to cDNA or molecules;
- (c) amplifying the cDNA molecules to a detectable concentration;
- (d) probing for the cDNA molecules complimentary to the desired miRNA markers;
- (e) determining a level of expression of the miRNA molecules within a sample from a subject by the level of cDNA molecules probed for the desired miRNA markers;
- and
- (f) using one or more Artificial Intelligence (AI) model to predict the disease condition of the subject.
A method of selecting a panel for use in disease diagnosis comprising the steps of:
- (a) selecting a group of miRNA molecules the differential expression of which may be associated with a disease condition;
- (b) transcribing the miRNA into cDNA;
- (c) determining the levels miRNA based on the cDNA in the sample;
- and
- (d) training one or more AI model to be able to predict the disease condition.
Dependencies are inferred from the claim text.